Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2014, Article ID 854124, 10 pages
http://dx.doi.org/10.1155/2014/854124
Research Article

Persistent Polyclonal B Cell Lymphocytosis B Cells Can Be Activated through CD40-CD154 Interaction

1Centre Universitaire d’Hématologie et d’Oncologie de Québec, CHU de Québec, Hôpital de l’Enfant-Jésus, 1401 18ième rue, Québec, QC, Canada G1J 1Z4
2Héma-Québec, Recherche et Développement, 1070 avenue des Sciences-de-la-Vie, Québec, QC, Canada G1V 5C3
3Département de Biochimie, de Microbiologie et de Bio-Informatique, Pavillon Alexandre-Vachon, 1045 avenue de la Médecine, Bureau 3428, Université Laval, Québec, QC, Canada G1V 0A6

Received 21 July 2014; Revised 19 November 2014; Accepted 20 November 2014; Published 14 December 2014

Academic Editor: Emili Montserrat

Copyright © 2014 Emmanuelle Dugas-Bourdages et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Gordon, B. M. Jones, S. W. Browning, T. J. Spira, and D. N. Lawrence, “Persistent polyclonal lymphocytosis of B lymphocytes,” The New England Journal of Medicine, vol. 307, no. 4, pp. 232–236, 1982. View at Google Scholar
  2. H. Mossafa, H. Malaure, M. Maynadie et al., “Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Francais d'Hematologie Cellulaire,” The British Journal of Haematology, vol. 104, no. 3, pp. 486–493, 1999. View at Google Scholar
  3. E. Callet-Bauchu, N. Renard, S. Gazzo et al., “Distribution of the cytogenetic abnormality +i(3)(q10) in persistent polyclonal B-cell lymphocytosis: a FICTION study in three cases,” British Journal of Haematology, vol. 99, no. 3, pp. 531–536, 1997. View at Google Scholar
  4. E. Cornet, J. F. Lesesve, H. Mossafa et al., “Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes,” Leukemia, vol. 23, no. 2, pp. 419–422, 2009. View at Google Scholar
  5. X. Troussard, H. Mossafa, G. Flandrin et al., “Identity between hairy B-cell lymphoproliferative disorder and persistent polyclonal B lymphocytosis?” Blood, vol. 90, no. 5, pp. 2110–2113, 1997. View at Google Scholar
  6. P. Feugier, A. K. De March, J. F. Lesesve et al., “Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasm,” Modern Pathology, vol. 17, no. 9, pp. 1087–1096, 2004. View at Google Scholar
  7. K. C. Carstairs, W. H. Francombe, J. G. Scott, and E. W. Gelfand, “Persistent polyclonal lymphocytosis of B lymphocytes, induced by cigarette smoking?” The Lancet, vol. 325, no. 8437, p. 1094, 1985. View at Publisher · View at Google Scholar
  8. P. Casassus, P. Lortholary, H. Komarover, F. Lejeune, and J. Hors, “Cigarette smoking-related persistent polyclonal B lymphocytosis. A premalignant state,” Archives of Pathology and Laboratory Medicine, vol. 111, no. 11, article 1081, 1987. View at Google Scholar
  9. M. A. Chan, S. H. Benedict, K. C. Carstairs, W. H. Francombe, and E. W. Gelfand, “Expansion of B lymphocytes with an unusual immunoglobulin rearrangement associated with atypical lymphocytosis and cigarette smoking,” The American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 6, pp. 549–552, 1990. View at Google Scholar
  10. A. Delannoy, D. Djian, G. Wallef et al., “Cigarette smoking and chronic polyclonal B-cell lymphocytosis,” Nouvelle Revue Francaise d'Hematologie, vol. 35, no. 2, pp. 141–144, 1993. View at Google Scholar · View at Scopus
  11. M. M. Loembe, S. Néron, R. Delage, and A. Darveau, “Analysis of expressed VH genes in persistent polyclonal B cell lymphocytosis reveals absence of selection in CD27+IgM+IgD+ memory B cells,” European Journal of Immunology, vol. 32, pp. 3678–3688, 2002. View at Publisher · View at Google Scholar
  12. R. Küppers, U. Klein, M.-L. Hansmann, and K. Rajewsky, “Cellular origin of human B-cell lymphomas,” The New England Journal of Medicine, vol. 341, no. 20, pp. 1520–1529, 1999. View at Google Scholar
  13. X. Troussard, H. Mossafa, F. Valensi et al., “Polyclonal lymphocytosis with binucleated peripheral lymphocytes. Morphological, immunological, cytogenetic and molecular analysis in 15 cases,” Presse Medicale, vol. 26, no. 19, pp. 895–899, 1997. View at Google Scholar · View at Scopus
  14. S. Agrawal, E. Matutes, J. Voke, M. J. S. Dyer, T. Khokhar, and D. Catovsky, “Persistent polyclonal B-cell lymphocytosis,” Leukemia Research, vol. 18, no. 10, pp. 791–795, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Roy, C. Ryckman, V. Bernier, R. Whittom, and R. Delage, “Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis,” Leukemia, vol. 12, no. 7, pp. 1026–1030, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Lawlor, M. Murray, D. S. O'Briain et al., “Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma,” Journal of Clinical Pathology, vol. 44, no. 4, pp. 341–342, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Schmidt-Hieber, T. Burmeister, A. Weimann et al., “Combined automated cell and flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocytosis (PPBL), a study of 25 patients,” Annals of Hematology, vol. 87, no. 10, pp. 829–836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Troussard, E. Cornet, J. F. Lesesve, C. Kourel, and H. Mossafa, “Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL),” OncoTargets and Therapy, vol. 1, pp. 59–66, 2008. View at Google Scholar
  19. R. Delage, L. Jacques, M. Massinga-Loembe et al., “Persistent polyclonal B-cell lymphocytosis: further evidence for a genetic disorder associated with B-cell abnormalities,” British Journal of Haematology, vol. 114, no. 3, pp. 666–670, 2001. View at Google Scholar
  20. R. Delage, J. Roy, L. Jacques, V. Bernier, J.-M. Delàge, and A. Darveau, “Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosis,” British Journal of Haematology, vol. 97, no. 3, pp. 589–595, 1997. View at Google Scholar
  21. A. Himmelmann, O. Gautschi, M. Nawrath, U. Bolliger, J. Fehr, and R. A. Stahel, “Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD+CD27+ memory B cells,” British Journal of Haematology, vol. 114, no. 2, pp. 400–405, 2001. View at Publisher · View at Google Scholar
  22. I. Salcedo, A. Campos-Caro, A. Sampalo, E. Reales, and J. A. Brieva, “Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment,” British Journal of Haematology, vol. 116, no. 3, pp. 662–666, 2002. View at Google Scholar
  23. I. Del Giudice, S. A. Pileri, M. Rossi et al., “Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly,” British Journal of Haematology, vol. 144, no. 5, pp. 726–731, 2009. View at Google Scholar
  24. J.-C. Weill, S. Weller, and C.-A. Reynaud, “Human marginal zone B cells,” Annual Review of Immunology, vol. 27, pp. 267–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. G. Tangye and K. L. Good, “Human IgM+CD27+ B cells: memory B cells or “memory” B cells?” The Journal of Immunology, vol. 179, no. 1, pp. 13–19, 2007. View at Google Scholar
  26. G. Van Kooten and J. Banchereau, “CD40-CD40 ligand,” Journal of Leukocyte Biology, vol. 67, no. 1, pp. 2–17, 2000. View at Google Scholar · View at Scopus
  27. J. Banchereau, P. de Paoli, A. Vallé, E. Garcia, and F. Rousset, “Long-term human B cell lines dependent on interleukin-4 and antibody to CD40,” Science, vol. 251, no. 4989, pp. 70–72, 1991. View at Google Scholar
  28. M. M. Loembé, J. Lamoureux, N. Deslauriers, A. Darveau, and R. Delage, “Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis,” British Journal of Haematology, vol. 113, no. 3, pp. 699–705, 2001. View at Google Scholar
  29. J. F. Fecteau and S. Néron, “CD40 stimulation of human peripheral B lymphocytes: distinct response from naïve and memory cells,” Journal of Immunology, vol. 171, no. 9, pp. 4621–4629, 2003. View at Google Scholar
  30. S. Néron, C. Racine, A. Roy, and M. Guérin, “Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction,” Immunology, vol. 116, no. 4, pp. 454–463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. F. Fecteau, A. Roy, and S. Néron, “Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction,” Immunology, vol. 128, no. 1, pp. e353–e365, 2009. View at Google Scholar
  32. S. Néron, L. Thibault, N. Dussault et al., “Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells,” Transfusion, vol. 47, no. 6, pp. 1042–1049, 2007. View at Google Scholar
  33. S. Néron, A. Pelletier, M.-C. Chevrier, G. Monier, R. Lemieux, and A. Darveau, “Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand,” Immunological Investigations, vol. 25, no. 1-2, pp. 79–89, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Weller, M. C. Braun, B. K. Tan et al., “Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire,” Blood, vol. 104, no. 12, pp. 3647–3654, 2004. View at Google Scholar
  35. C. Werner-Favre, F. Bovia, P. Schneider et al., “IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells,” European Journal Immunology, vol. 31, pp. 243–249, 2001. View at Publisher · View at Google Scholar
  36. V. Lougaris, R. Badolato, S. Ferrari, and A. Plebani, “Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features,” Immunological Reviews, vol. 203, pp. 48–66, 2005. View at Google Scholar
  37. N. S. Longo, P. L. Lugar, S. Yavuz et al., “Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting,” Blood, vol. 113, no. 16, pp. 3706–3715, 2009. View at Google Scholar
  38. L. A. Vogel and R. J. Noelle, “CD40 and its crucial role as a member of the TNFR family,” Seminars in Immunology, vol. 10, no. 6, pp. 435–442, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. R. C. Allen, R. J. Armitage, M. E. Conley et al., “CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome,” Science, vol. 259, no. 5097, pp. 990–993, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. J. P. DiSanto, J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. de Saint Basile, “CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM,” Nature, vol. 361, no. 6412, pp. 541–543, 1993. View at Google Scholar
  41. U. Korthauer, D. Graf, H. W. Mages et al., “Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM,” Nature, vol. 361, no. 6412, pp. 539–541, 1993. View at Publisher · View at Google Scholar · View at Scopus
  42. M. E. Conley, M. Larché, V. R. Bonagura et al., “Hyper IgM syndrome associated with defective CD40-mediated B cell activation,” Journal of Clinical Investigation, vol. 94, no. 4, pp. 1404–1409, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Durandy, C. Hivroz, F. Mazerolles et al., “Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression,” The Journal of Immunology, vol. 158, no. 6, pp. 2576–2584, 1997. View at Google Scholar
  44. V. Pascual, Y.-J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J. D. Capra, “Analysis of somatic mutation in five B cell subsets of human tonsil,” The Journal of Experimental Medicine, vol. 180, no. 1, pp. 329–339, 1994. View at Google Scholar
  45. K. Hafraoui, M. Moutschen, J. Smet, F. Mascart, N. Schaaf-Lafontaine, and G. Fillet, “Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis,” European Journal of Internal Medicine, vol. 20, no. 3, pp. e62–e65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. Berkowska, C. Grosserichter-Wagener, H. J. Adriaansen et al., “Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+IgM+IgD+ memory B cells with a distinctive immunophenotype,” Leukemia, vol. 28, pp. 1560–1564, 2014. View at Google Scholar